Ramelteon in Adults With Chronic Insomnia

Status:
Completed

Trial end date:
2003-09-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety and efficacy of Ramelteon, once daily (QD), in adult subjects with chronic insomnia.

Phase 3

Takeda